Concepedia

Luis A. Carvajal

LA

Statistics

Publications

12

Citations

1.3K

H-Index

12

Active since

2012

Affiliations

Albert Einstein College of Medicine(Current)

Montefiore Medical Center

Icahn School of Medicine at Mount Sinai

Aileron (United States)

The University of Texas MD Anderson Cancer Center

Luis A. Carvajal is an author at Albert Einstein College of Medicine specializing in molecular oncology, oncology, and medicine.

ORCID

Publications per year

2012–2023

12

Publications

12

New IDH1 mutant inhibitors for treatment of acute myeloid leukemia

Ujunwa Cynthia Okoye-Okafor, Boris Bartholdy, Jessy Cartier et al. · Nature Chemical Biology · 2015 · 176 citations · Full text

, , +12

Pharmacologic Activation of p53 Triggers Viral Mimicry Response Thereby Abolishing Tumor Immune Evasion and Promoting Antitumor Immunity

Xiaolei Zhou, Madhurendra Singh, Gema Sanz et al. · Cancer Discovery · 2021 · 174 citations · Full text

, , +17

E2F7, a novel target, is up-regulated by p53 and mediates DNA damage-dependent transcriptional repression

Luis A. Carvajal, Pierre-Jacques Hamard, Crystal A. Tonnessen-Murray et al. · Genes & Development · 2012 · 157 citations · Full text

, , +16

Minimal PU.1 reduction induces a preleukemic state and promotes development of acute myeloid leukemia

Britta Will, Thomas O. Vogler, Swathi Narayanagari et al. · Nature Medicine · 2015 · 128 citations

, , +10

Discovery of Sulanemadlin (ALRN-6924), the First Cell-Permeating, Stabilized α-Helical Peptide in Clinical Development

Vincent Guerlavais, Tomi K. Sawyer, Luis A. Carvajal et al. · Journal of Medicinal Chemistry · 2023 · 125 citations · Full text

, , +14

1–5 of 12